A Hydrophilic Dental Implant Surface Exhibit Thrombogenic Properties In Vitro

Clinical Implant Dentistry and Related Research

Volumn 15, Issue 1, 2013, Pages 105-112

  Hong, Jaan ^a   Kurt, Seta ^a   Thor, Andreas ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Coagulation; Complement; Contact phase activation; Dental implant; Hydrophilicity; Osseointegration; Platelet activation; Surface modification; Titanium

Indexed keywords

BETA THROMBOGLOBULIN; CITRIC ACID; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5B; EDETIC ACID; THROMBOSPONDIN; TITANIUM;

ARTICLE; BLOOD CLOTTING; BONE REGENERATION; CHEMICAL PHENOMENA; CHEMISTRY; DENTAL ACID ETCHING; SURFACE PROPERTY; THROMBOCYTE ACTIVATION; TOOTH IMPLANT;

ACID ETCHING, DENTAL; BETA-THROMBOGLOBULIN; BLOOD COAGULATION; CITRIC ACID; COMPLEMENT C3A; COMPLEMENT C5B; DENTAL IMPLANTS; EDETIC ACID; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; OSSEOINTEGRATION; PLATELET ACTIVATION; SURFACE PROPERTIES; THROMBOSPONDINS; TITANIUM;

EID: 84873058670     PISSN: 15230899     EISSN: 17088208     Source Type: Journal    
DOI: 10.1111/j.1708-8208.2011.00362.x     Document Type: Article

References (41)

1. Morton D, Bornstein MM, Wittneben JG, etal. Early loading after 21days of healing of nonsubmerged titanium implants with a chemically modified sandblasted and acid-etched surface: two-year results of a prospective two-center study. Clin Implant Dent Relat Res 2010; 12:9-17.
2. Schliephake H, Scharnweberb D. Chemical and biological functionalization of titanium for dental implants. J Mater Chem 2008; 18:2404-2414.
3. Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997; 55:1294-1299.
4. Zawicki DF, Jain RK, Schmid-Schoenbein GW, Chien S. Dynamics of neovascularization in normal tissue. Microvasc Res 1981; 21:27-47.
5. Gerngross H, Burri C, Claes L. Experimental studies on the influence of fibrin adhesive, factor XIII, and calcitonin on the incorporation and remodeling of autologous bone grafts. Arch Orthop Trauma Surg 1986; 106:23-31.
6. Kalebo P, Buch F, Albrektsson T. Bone formation rate in osseointegrated titanium implants. Influence of locally applied haemostasis, peripheral blood, autologous bone marrow and fibrin adhesive system (FAS). Scand J Plast Reconstr Surg Hand Surg 1988; 22:53-60.
7. Davies JE. Understanding peri-implant endosseous healing. J Dent Educ 2003; 67:932-949.
8. Thor A, Rasmusson L, Wennerberg A, etal. The role of whole blood in thrombin generation in contact with various titanium surfaces. Biomaterials 2007; 28:966-974.
9. Schwarz F, Herten M, Sager M, Wieland M, Dard M, Becker J. Histological and immunohistochemical analysis of initial and early osseous integration at chemically modified and conventional SLA titanium implants: preliminary results of a pilot study in dogs. Clin Oral Implants Res 2007; 18:481-488.
10. Johnell M, Larsson R, Siegbahn A. The influence of different heparin surface concentrations and antithrombin-binding capacity on inflammation and coagulation. Biomaterials 2005; 26:1731-1739.
11. Hong J, Nilsson Ekdahl K, Reynolds H, Larsson R, Nilsson B. A new in vitro model to study interaction between whole blood and biomaterials. Studies of platelet and coagulation activation and the effect of aspirin. Biomaterials 1999; 20:603-611.
12. Sanchez J, Lundquist PB, Elgue G, Larsson R, Olsson P. Measuring the degree of plasma contact activation induced by artificial materials. Thromb Res 2002; 105:407-412.
13. Nilsson Ekdahl K, Nilsson B, Pekna M, Nilsson UR. Generation of iC3 on the interphase between blood and gas. Scand J Immunol 1992; 35:85-91.
14. Mollnes TE, Lea T, Froland SS, Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 1985; 22:197-202.
15. Hong J, Andersson J, Ekdahl KN, etal. Titanium is a highly thrombogenic biomaterial: possible implications for osteogenesis. Thromb Haemost 1999; 82:58-64.
16. Vogler EA, Siedlecki CA. Contact activation of blood-plasma coagulation. Biomaterials 2009; 30:1857-1869.
17. Gebbink MF, Bouma B, Maas C, Bouma BN. Physiological responses to protein aggregates: fibrinolysis, coagulation and inflammation (new roles for old factors). FEBS Lett 2009; 583:2691-2699.
18. Sanchez J, Elgue G, Larsson R, Nilsson B, Olsson P. Surface-adsorbed fibrinogen and fibrin may activate the contact activation system. Thromb Res 2008; 122:257-263.
19. Keere IV, Willaert R, Hubin A, Vereecken J. Interaction of human plasma fibrinogen with commercially pure titanium as studied with atomic force microscopy and X-ray photoelectron spectroscopy. Langmuir 2008; 24:1844-1852.
20. Broberg M, Eriksson C, Nygren H. GpIIb/IIIa is the main receptor for initial platelet adhesion to glass and titanium surfaces in contact with whole blood. J Lab Clin Med 2002; 139:163-172.
21. Back J, Lang MH, Elgue G, etal. Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces. Biomaterials 2009; 30:6573-6580.
22. Back J, Sanchez J, Elgue G, Ekdahl KN, Nilsson B. Activated human platelets induce factor XIIa-mediated contact activation. Biochem Biophys Res Commun 2010; 391:11-17.
23. Yahyapour N, Eriksson C, Malmberg P, Nygren H. Thrombin, kallikrein and complement C5b-9 adsorption on hydrophilic and hydrophobic titanium and glass after short time exposure to whole blood. Biomaterials 2004; 25:3171-3176.
24. Tanaka A, Suzuki Y, Sugihara K, Kanayama N, Urano T. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro. Life Sci 2009; 85:220-225.
25. Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev 2007; 21:131-142.
26. Neuss S, Schneider RK, Tietze L, Knuchel R, Jahnen-Dechent W. Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots. Cells Tissues Organs 2009; 191:36-46.
27. Brill A, Elinav H, Varon D. Differential role of platelet granular mediators in angiogenesis. Cardiovasc Res 2004; 63:226-235.
28. Langer HF, Gawaz M. Platelets in regenerative medicine. Basic Res Cardiol 2008; 103:299-307.
29. Parsons P, Butcher A, Hesselden K, etal. Platelet-rich concentrate supports human mesenchymal stem cell proliferation, bone morphogenetic protein-2 messenger RNA expression, alkaline phosphatase activity, and bone formation in vitro: a mode of action to enhance bone repair. J Orthop Trauma 2008; 22:595-604.
30. Jung J, Moon N, Ahn JY, etal. Mesenchymal stromal cells expanded in human allogenic cord blood serum display higher self-renewal and enhanced osteogenic potential. Stem Cells Dev 2009; 18:559-571.
31. Ghajar CM, Blevins KS, Hughes CC, George SC, Putnam AJ. Mesenchymal stem cells enhance angiogenesis in mechanically viable prevascularized tissues via early matrix metalloproteinase upregulation. Tissue Eng 2006; 12:2875-2888.
32. Simman R, Hoffmann A, Bohinc RJ, Peterson WC, Russ AJ. Role of platelet-rich plasma in acceleration of bone fracture healing. Ann Plast Surg 2008; 61:337-344.
33. Wolff R, Plow EF, Ginsberg MH. Interaction of thrombospondin with resting and stimulated human platelets. J Biol Chem 1986; 261:6840-6846.
34. Huber S, Schramm C. TGF-beta and CD4+CD25+ regulatory T cells. Front Biosci 2006; 11:1014-1023.
35. Ni Choileain N, MacConmara M, Zang Y, Murphy TJ, Mannick JA, Lederer JA. Enhanced regulatory T cell activity is an element of the host response to injury. J Immunol 2006; 176:225-236.
36. Suska F, Esposito M, Gretzer C, Kalltorp M, Tengvall P, Thomsen P. IL-1alpha, IL-1beta and TNF-alpha secretion during in vivo/ex vivo cellular interactions with titanium and copper. Biomaterials 2003; 24:461-468.
37. Edgington TS, Curtiss LK, Plow EF. A linkage between the hemostatic and immune systems embodied in the fibrinolytic release of lymphocyte suppressive peptides. J Immunol 1985; 134:471-477.
38. Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421:388-392.
39. Elwing H, Nilsson B, Svensson K-E, Nilsson UR, Askendahl A, Lundström I. Conformational changes of a model protein (complement factor 3) adsorbed on hydrophilic and hydrophobic solid surfaces. J Colloid Interface Sci 1987; 125:139-145.
40. Hamad OA, Ekdahl KN, Nilsson PH, etal. Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets. J Thromb Haemost 2008; 6:1413-1421.
41. Wang YS, Zhang S, Zeng XT, Cheng K, Qian M, Weng WJ. In vitro behavior of fluoridated hydroxyapatite coatings in organic-containing simulated body fluid. Mater Sci Eng C-Biomimetic Supramol Syst 2007; 27:244-250.